Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

NCT03838926 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Hematologic Malignancies

Interventions

DRUG: Trichostatin A

Sponsor

Vanda Pharmaceuticals